Linklaters has advised Jacobs Capital on its disposal of Stingray Healthcare to Amethyst Radiotherapy. Jacobs Capital has completed the disposal of Stingray Healthcare to Amethyst Radiotherapy,...
Jacobs Capital Sells Stingray Healthcare to Amethyst Radiotherapy
Carlyle’s €250 Million Strategic Investment in Sanoptis
Linklaters advised Carlyle on the deal. Carlyle, the global investment firm, has completed its €250 million strategic investment in Sanoptis, a European leader in ophthalmology services....


























